Kolocassides K G, Galinanes M, Hearse D J
Cardiovascular Research, the Rayne Institute, St Thomas' Hospital, London, UK.
Circulation. 1996 May 1;93(9):1725-33. doi: 10.1161/01.cir.93.9.1725.
Acceleration of ischemic contracture is conventionally accepted as a predictor of poor postischemic function. Hence, protective interventions such as cardioplegia delay ischemic contracture and improve postischemic contractile recovery. We compared the effect of ischemic preconditioning and cardioplegia (alone and in combination) on ischemic contracture and postischemic contractile recovery.
Isolated rat hearts were aerobically perfused with blood for 20 minutes before being subjected to zero-flow normothermic global ischemia for 35 minutes and reperfusion for 40 minutes. Hearts were perfused at a constant pressure for 60 mm Hg and were paced at 360 beats per minute. Left ventricular developed pressure and ischemic contracture were assessed with an intraventricular balloon. Four groups (n=8 hearts per group) were studied: control hearts with 35 minutes of unprotected ischemia, hearts preconditioned with one cycle of 3 minutes of ischemia plus 3 minutes of reperfusion before 35 minutes of ischemia, hearts subjected to cardioplegia with St Thomas' solution infused for 1 minute before 35 minutes of ischemia, and hearts subjected to preconditioning plus cardioplegia before 35 minutes of ischemia. After 40 minutes of reperfusion, each intervention produced a similar improvement in postischemic left ventricular development pressure (expressed as a percentage of its preischemic value: preconditioning, 44 +/- 2%; cardioplegia, 53 +/- 3%; preconditioning plus cardioplegia, 54 +/- 4% and control, 26 +/- 6%, P<.05). However, preconditioning accelerated whereas cardioplegia delayed ischemic contracture; preconditioning plus cardioplegia gave an intermediate result. Thus, times to 75% contracture were as follows: control, 14.3 +/- 0.4 minutes; preconditioning, 6.2 +/- 0.3 minutes; cardioplegia 23.9 +/- 0.8 minutes; and preconditioning plus cardioplegia 15.4 +/- 2.4 minutes (P<.05 preconditioning and cardioplegia versus control). In additional experiments, using blood- and crystalloid-perfused hearts, we describe the relationship between the number of preconditioning cycles and ischemic contracture.
Although preconditioning accelerates, cardioplegia delays, and preconditioning plus cardioplegia has little effect on ischemic contracture, each affords similar protection of postischemic contractile function. These results question the utility of ischemic contracture as a predictor of the protective efficacy of anti-ischemic interventions. They also suggest that preconditioning and cardioplegia may act through very different mechanisms.
缺血性挛缩的加速传统上被认为是缺血后功能不良的一个预测指标。因此,诸如心脏停搏液等保护性干预措施可延迟缺血性挛缩并改善缺血后收缩功能的恢复。我们比较了缺血预处理和心脏停搏液(单独使用及联合使用)对缺血性挛缩和缺血后收缩功能恢复的影响。
将离体大鼠心脏在有氧条件下用血液灌注20分钟,然后进行35分钟的零流量常温全心缺血及40分钟的再灌注。心脏在60毫米汞柱的恒定压力下灌注,并以每分钟360次心跳进行起搏。使用心室内球囊评估左心室舒张末压和缺血性挛缩。研究了四组(每组n = 8个心脏):经历35分钟未受保护缺血的对照心脏;在35分钟缺血前经一个3分钟缺血加3分钟再灌注周期预处理的心脏;在35分钟缺血前用圣托马斯液灌注心脏停搏1分钟的心脏;以及在35分钟缺血前进行预处理加心脏停搏的心脏。再灌注40分钟后,每种干预措施对缺血后左心室舒张末压均产生了类似的改善(以缺血前值的百分比表示:预处理组为44±2%;心脏停搏液组为53±3%;预处理加心脏停搏液组为54±4%;对照组为26±6%,P<0.05)。然而,预处理加速了缺血性挛缩,而心脏停搏液则延迟了缺血性挛缩;预处理加心脏停搏液产生了中间结果。因此,达到75%挛缩的时间如下:对照组为14.3±0.4分钟;预处理组为6.2±0.3分钟;心脏停搏液组为23.9±0.8分钟;预处理加心脏停搏液组为15.4±2.4分钟(预处理组和心脏停搏液组与对照组相比,P<0.05)。在另外的实验中,使用血液和晶体液灌注的心脏,我们描述了预处理周期数与缺血性挛缩之间的关系。
尽管预处理加速缺血性挛缩,心脏停搏液延迟缺血性挛缩,预处理加心脏停搏液对缺血性挛缩影响不大,但每种方法对缺血后收缩功能均提供了类似的保护。这些结果质疑了缺血性挛缩作为抗缺血干预措施保护效果预测指标的实用性。它们还表明预处理和心脏停搏液可能通过非常不同的机制起作用。